ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

NCI Pushes For Hop Concept Review In October; CHOPs Seek Institutions To Volunteer As Evaluations Controls

September 18, 1981

Funding opportunities listed.

November 12, 2004

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976